Literature DB >> 22174157

Functional heterogeneity of human effector CD8+ T cells.

Hiroshi Takata1, Takuya Naruto, Masafumi Takiguchi.   

Abstract

Effector CD8(+) T cells are believed to be terminally differentiated cells having cytotoxic activity and the ability to produce effector cytokines such as INF-γ and TNF-α. We investigated the difference between CXCR1(+) and CXCR1(-) subsets of human effector CD27(-)CD28(-)CD8(+) T cells. The subsets expressed cytolytic molecules similarly and exerted substantial cytolytic activity, whereas only the CXCR1(-) subset had IL-2 productivity and self-proliferative activity and was more resistant to cell death than the CXCR1(+) subset. These differences were explained by the specific up-regulation of CAMK4, SPRY2, and IL-7R in the CXCR1(-) subset and that of pro-apoptotic death-associated protein kinase 1 (DAPK1) in the CXCR1(+) subset. The IL-2 producers were more frequently found in the IL-7R(+) subset of the CXCR1(-) effector CD8(+) T cells than in the IL-7R(-) subset. IL-7/IL-7R signaling promoted cell survival only in the CXCR1(-) subset. The present study has highlighted a novel subset of effector CD8(+) T cells producing IL-2 and suggests the importance of this subset in the homeostasis of effector CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22174157     DOI: 10.1182/blood-2011-03-343251

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Single-cell mass cytometry for analysis of immune system functional states.

Authors:  Zach B Bjornson; Garry P Nolan; Wendy J Fantl
Journal:  Curr Opin Immunol       Date:  2013-08-31       Impact factor: 7.486

Review 2.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

3.  Low Serum Calcium Concentration in Patients With Systemic Lupus Erythematosus Accompanied by the Enhanced Peripheral Cellular Immunity.

Authors:  Xue Du; Di Zhao; Ying Wang; Zhengyi Sun; Qiuyang Yu; Hongyu Jiang; Liying Wang
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

4.  NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells.

Authors:  Bin Zhong; Jie Zheng; Huilan Wen; Xinhui Liao; Xingxiang Chen; Yunwei Rao; Ping Yuan
Journal:  Genes Genomics       Date:  2022-03-30       Impact factor: 2.164

5.  Sprouty-2 regulates HIV-specific T cell polyfunctionality.

Authors:  Yen-Ling Chiu; Liang Shan; Hailiang Huang; Carl Haupt; Catherine Bessell; David H Canaday; Hao Zhang; Ya-Chi Ho; Jonathan D Powell; Mathias Oelke; Joseph B Margolick; Joel N Blankson; Diane E Griffin; Jonathan P Schneck
Journal:  J Clin Invest       Date:  2014-01       Impact factor: 14.808

6.  Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes.

Authors:  Karine Haurogné; Marija Pavlovic; Hélène Rogniaux; Jean-Marie Bach; Blandine Lieubeau
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 7.  Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T Cells.

Authors:  Joana Dias; Caroline Boulouis; Michał J Sobkowiak; Kerri G Lal; Johanna Emgård; Marcus Buggert; Tiphaine Parrot; Jean-Baptiste Gorin; Edwin Leeansyah; Johan K Sandberg
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

8.  Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells.

Authors:  Tatjana Nikolic; Bart O Roep
Journal:  Front Immunol       Date:  2013-05-14       Impact factor: 7.561

9.  Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.

Authors:  Jang-Jaer Lee; Chiou-Yueh Yeh; Chiau-Jing Jung; Ching-Wen Chen; Mao-Kuang Du; Hui-Ming Yu; Chia-Ju Yang; Hui-Yi Lin; Andy Sun; Jenq-Yuh Ko; Shih Jung Cheng; Yen-Liang Chang; Jean-San Chia
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.